Published in Cancer Weekly, March 16th, 2004
"We have analyzed mammary tumors arising in transgenic mice expressing a novel, multifunctional RNA-binding protein. The protein, which we call the c-inyc mRNA coding region instability determinant binding protein (CRD-BP), binds to c-myc, insulin-like growth factor 11, and beta-actin mRNAs, and to H19 RNA. Depending on the RNA substrate, the CRD-BP affects RNA localization, translation, or stability," scientists in the United States report.
"CRD-BP levels are high during fetal development but low or undetectable in normal adult tissues," said Charles R. Tessier and colleagues at...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.